NextPlat (NXPL) Goodwill & Intangibles (2015 - 2026)
NextPlat's (NXPL) quarterly Goodwill & Intangibles came in at $527000.0 in Q2 2026, down 47.61% year-over-year from $1.0 million in Q2 2025, and down 8.82% quarter-over-quarter from $578000.0 in Q4 2025.
Analysis
NextPlat (NXPL) Goodwill & Intangibles (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Goodwill & Intangibles for 12 consecutive years, with $527000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Goodwill & Intangibles fell 47.61% year-over-year to $527000.0 in Q2 2026; TTM through Jun 2026 was $527000.0, a 47.61% decrease from a year earlier, with the FY2025 full-year figure at $578000.0, down 44.95% from the prior year.
- Goodwill & Intangibles was $527000.0 for Q2 2026 at NextPlat, down from $578000.0 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $30.6 million in Q4 2023 and troughed at $37500.0 in Q2 2023.
- A 5-year average of $4.2 million and a median of $756000.0 in 2024 frame the typical range for Goodwill & Intangibles.
- The widest YoY moves for Goodwill & Intangibles: up 38050.86% in 2024, down 96.57% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $250000.0 in 2022, then soared by 12134.4% to $30.6 million in 2023, then tumbled by 96.57% to $1.0 million in 2024, then plunged by 44.95% to $578000.0 in 2025, then dropped by 8.82% to $527000.0 in 2026.
- The last three Goodwill & Intangibles figures came in at $527000.0 (Q2 2026), $578000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 527,000.00 |
| Dec 31, 2025 | 578,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 901,000.00 |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 16.69 Mn |
| Dec 31, 2023 | 30.59 Mn |
| Sep 30, 2023 | 17.26 Mn |
| Jun 30, 2023 | 37,500.00 |
| Mar 31, 2023 | 43,750.00 |
| Dec 31, 2022 | 250,000.00 |
| Sep 30, 2022 | 56,250.00 |
| Jun 30, 2022 | 62,500.00 |
| Mar 31, 2022 | 68,750.00 |
| Dec 31, 2021 | 75,000.00 |
| Sep 30, 2021 | 81,250.00 |
| Jun 30, 2021 | 87,500.00 |